-
1
-
-
85036637180
-
Barriers and facilitators to dispensing of intranasal naloxone by pharmacists
-
Bakhireva, L.N., Bautista, A., Cano, S., Shrestha, S., Bachyrycz, A.M., Cruz, T.H., Barriers and facilitators to dispensing of intranasal naloxone by pharmacists. Subst. Abus. 5 (2017), 1–11.
-
(2017)
Subst. Abus.
, vol.5
, pp. 1-11
-
-
Bakhireva, L.N.1
Bautista, A.2
Cano, S.3
Shrestha, S.4
Bachyrycz, A.M.5
Cruz, T.H.6
-
2
-
-
33846454391
-
Physicians’ knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities
-
Beletsky, L., Ruthazer, R., Macalino, G.E., Rich, J.D., Tan, L., Burris, S., Physicians’ knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J. Urban Health 84 (2007), 126–136.
-
(2007)
J. Urban Health
, vol.84
, pp. 126-136
-
-
Beletsky, L.1
Ruthazer, R.2
Macalino, G.E.3
Rich, J.D.4
Tan, L.5
Burris, S.6
-
3
-
-
79751513984
-
Stopping an invisible epidemic: legal issues in the provision of naloxone to prevent opioid overdose
-
Burris, S., Beletsky, L., Castagna, C., Coyle, C., Crowe, C., McLaughlin, J., Stopping an invisible epidemic: legal issues in the provision of naloxone to prevent opioid overdose. Drexel Law Rev. 1 (2009), 273–339.
-
(2009)
Drexel Law Rev.
, vol.1
, pp. 273-339
-
-
Burris, S.1
Beletsky, L.2
Castagna, C.3
Coyle, C.4
Crowe, C.5
McLaughlin, J.6
-
4
-
-
85048164042
-
-
Centers for Disease Control and Prevention. Data Use Restrictions. (Accessed 23 January 2018).
-
Centers for Disease Control and Prevention, 2017. Data Use Restrictions. https://wonder.cdc.gov/datause.html. (Accessed 23 January 2018).
-
(2017)
-
-
-
5
-
-
0028053792
-
A comprehensive review of naloxone for the emergency physician
-
Chamberlain, J.M., Klein, B.L., A comprehensive review of naloxone for the emergency physician. Am. J. Emerg. Med. 12 (1994), 650–660.
-
(1994)
Am. J. Emerg. Med.
, vol.12
, pp. 650-660
-
-
Chamberlain, J.M.1
Klein, B.L.2
-
6
-
-
84961391909
-
Legal changes to increase access to naloxone for opioid overdose reversal in the United States
-
Davis, C., Carr, D., Legal changes to increase access to naloxone for opioid overdose reversal in the United States. Drug Alcohol Depend. 157 (2015), 112–120.
-
(2015)
Drug Alcohol Depend.
, vol.157
, pp. 112-120
-
-
Davis, C.1
Carr, D.2
-
7
-
-
85020447008
-
State legal innovations to encourage naloxone dispensing
-
Davis, C., Carr, D., State legal innovations to encourage naloxone dispensing. J. Am. Pharm. Assoc. 57 (2017), S180–S184.
-
(2017)
J. Am. Pharm. Assoc.
, vol.57
, pp. S180-S184
-
-
Davis, C.1
Carr, D.2
-
8
-
-
84876988116
-
Changing law from barrier to facilitator of opioid overdose prevention
-
Davis, C., Webb, D., Burris, S., Changing law from barrier to facilitator of opioid overdose prevention. J. Law Med. Ethics 41 (2013), 33–36.
-
(2013)
J. Law Med. Ethics
, vol.41
, pp. 33-36
-
-
Davis, C.1
Webb, D.2
Burris, S.3
-
9
-
-
84908118490
-
Emergency medical services naloxone access: a national systematic legal review
-
Davis, C.S., Southwell, J.K., Niehaus, V.R., Walley, A.Y., Dailey, M.W., Emergency medical services naloxone access: a national systematic legal review. Acad. Emerg. Med. 21 (2014), 1173–1177.
-
(2014)
Acad. Emerg. Med.
, vol.21
, pp. 1173-1177
-
-
Davis, C.S.1
Southwell, J.K.2
Niehaus, V.R.3
Walley, A.Y.4
Dailey, M.W.5
-
10
-
-
84995618154
-
Co-prescribing naloxone does not increase liability risk
-
Davis, C., Beletsky, L., Burris, S., Binswanger, I.A., Co-prescribing naloxone does not increase liability risk. Subst. Abus. 37 (2016), 498–500.
-
(2016)
Subst. Abus.
, vol.37
, pp. 498-500
-
-
Davis, C.1
Beletsky, L.2
Burris, S.3
Binswanger, I.A.4
-
11
-
-
84951173862
-
Syringe service programs for persons who inject drugs in urban, suburban, and rural areas—United States, 2013
-
Des Jarlais, D.C., Nugent, A., Solberg, A., Feelemyer, J., Mermin, J., Holtzman, D., Syringe service programs for persons who inject drugs in urban, suburban, and rural areas—United States, 2013. MMWR Morb. Mortal. Wkly. Rep. 64 (2015), 1337–1341.
-
(2015)
MMWR Morb. Mortal. Wkly. Rep.
, vol.64
, pp. 1337-1341
-
-
Des Jarlais, D.C.1
Nugent, A.2
Solberg, A.3
Feelemyer, J.4
Mermin, J.5
Holtzman, D.6
-
12
-
-
85040075835
-
Underlying factors in drug overdose deaths
-
Dowell, D., Noonan, K.R., Houry, D., Underlying factors in drug overdose deaths. JAMA 318 (2017), 2295–2296.
-
(2017)
JAMA
, vol.318
, pp. 2295-2296
-
-
Dowell, D.1
Noonan, K.R.2
Houry, D.3
-
13
-
-
84938608230
-
Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis
-
Giglio, R.E., Li, G., DiMaggio, C.J., Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj. Epidemiol., 2, 2015, 10.
-
(2015)
Inj. Epidemiol.
, vol.2
, pp. 10
-
-
Giglio, R.E.1
Li, G.2
DiMaggio, C.J.3
-
14
-
-
85003434291
-
The rising price of naloxone—risks to efforts to stem overdose deaths
-
Gupta, R., Shah, N.D., Ross, J.S., The rising price of naloxone—risks to efforts to stem overdose deaths. N. Eng. J. Med. 375 (2016), 2213–2215.
-
(2016)
N. Eng. J. Med.
, vol.375
, pp. 2213-2215
-
-
Gupta, R.1
Shah, N.D.2
Ross, J.S.3
-
15
-
-
85024893153
-
Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?
-
Koester, S., Mueller, S.R., Raville, L., Langegger, S., Binswanger, I.A., Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?. Int. J. Drug Policy 48 (2017), 115–124.
-
(2017)
Int. J. Drug Policy
, vol.48
, pp. 115-124
-
-
Koester, S.1
Mueller, S.R.2
Raville, L.3
Langegger, S.4
Binswanger, I.A.5
-
16
-
-
85037626624
-
Identifying gaps in the implementation of naloxone programs for laypersons in the United States
-
Lambdin, B.H., Zibbell, J., Wheeler, E., Kral, A.H., Identifying gaps in the implementation of naloxone programs for laypersons in the United States. Int. J. Drug Policy 52 (2018), 52–55.
-
(2018)
Int. J. Drug Policy
, vol.52
, pp. 52-55
-
-
Lambdin, B.H.1
Zibbell, J.2
Wheeler, E.3
Kral, A.H.4
-
17
-
-
33748455452
-
Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths
-
Maxwell, S., Bigg, D., Stanczykiewicz, K., Carlberg-Racich, S., Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J. Addict. Dis. 25 (2006), 89–96.
-
(2006)
J. Addict. Dis.
, vol.25
, pp. 89-96
-
-
Maxwell, S.1
Bigg, D.2
Stanczykiewicz, K.3
Carlberg-Racich, S.4
-
18
-
-
2442676752
-
Physiological and pathological responses to hypoxia
-
Michiels, C., Physiological and pathological responses to hypoxia. Am. J. Pathol. 164 (2004), 1875–1882.
-
(2004)
Am. J. Pathol.
, vol.164
, pp. 1875-1882
-
-
Michiels, C.1
-
19
-
-
85048175972
-
-
NIH/NIDA. Overdose Death Rates. (Accessed 24 September 2017).
-
NIH/NIDA, 2017. Overdose Death Rates. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. (Accessed 24 September 2017).
-
(2017)
-
-
-
20
-
-
84983665953
-
Increases in fentanyl-related overdose deaths—Florida and Ohio, 2013–2015
-
Peterson, A.B., Gladden, R.M., Delcher, C., Spies, E., Garcia-Williams, A., Wang, Y., Halpin, J., Zibbell, J., McCarty, C.L., DeFiore-Hyrmer, J., DiOrio, M., Goldberger, B.A., Increases in fentanyl-related overdose deaths—Florida and Ohio, 2013–2015. MMWR Morb. Mortal. Wkly. Rep. 65 (2016), 844–849.
-
(2016)
MMWR Morb. Mortal. Wkly. Rep.
, vol.65
, pp. 844-849
-
-
Peterson, A.B.1
Gladden, R.M.2
Delcher, C.3
Spies, E.4
Garcia-Williams, A.5
Wang, Y.6
Halpin, J.7
Zibbell, J.8
McCarty, C.L.9
DeFiore-Hyrmer, J.10
DiOrio, M.11
Goldberger, B.A.12
-
21
-
-
85048180758
-
-
Prescription Drug Abuse Policy System. Naloxone overdose prevention laws. Retrieved from: (Accessed 15 August 2016).
-
Prescription Drug Abuse Policy System, 2016. Naloxone overdose prevention laws. Retrieved from: http://www.pdaps.org/dataset/overview/laws-regulating-administration-of-naloxone/. (Accessed 15 August 2016).
-
(2016)
-
-
-
22
-
-
84890331880
-
Hot spots in mortality from drug poisoning in the United States, 2007–2009
-
Rossen, L.M., Khan, D., Warner, M., Hot spots in mortality from drug poisoning in the United States, 2007–2009. Health Place 26 (2014), 14–20.
-
(2014)
Health Place
, vol.26
, pp. 14-20
-
-
Rossen, L.M.1
Khan, D.2
Warner, M.3
-
23
-
-
85048156041
-
-
Spatiotemporal variation in selected health outcomes from the National Vital Statistics System. Presented at: 2015 National Conference on Health Statistics, August 25, Bethesda, MD. Available from: (Accessed 7 September 2017).
-
Rossen, L., Khan, D., Hamilton, B., Warner, M., 2015. Spatiotemporal variation in selected health outcomes from the National Vital Statistics System. Presented at: 2015 National Conference on Health Statistics, August 25, 2015, Bethesda, MD. Available from: http://www.cdc.gov/nchs/ppt/nchs2015/Rossen_Tuesday_WhiteOak_BB3.pdf. (Accessed 7 September 2017).
-
(2015)
-
-
Rossen, L.1
Khan, D.2
Hamilton, B.3
Warner, M.4
-
24
-
-
85048199970
-
-
Drug poisoning mortality: United States–2015. National Center for Health Statistics. Available at: (Accessed 7 September 2017)., 1999
-
Rossen, L., Bastian, B., Warner, M., Khan, D., Chong, Y., 2017. Drug poisoning mortality: United States, 1999–2015. National Center for Health Statistics. Available at: https://www.cdc.gov/nchs/data-visualization/drug-poisoning-mortality/#notes. (Accessed 7 September 2017).
-
(2017)
-
-
Rossen, L.1
Bastian, B.2
Warner, M.3
Khan, D.4
Chong, Y.5
-
25
-
-
84955313404
-
Increases in drug and opioid overdose deaths—United States, 2000–2014
-
Rudd, R., Aleshire, N., Zibbell, J., Gladden, R., Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR Morb. Mortal. Wkly. Rep. 64 (2015), 1378–1382.
-
(2015)
MMWR Morb. Mortal. Wkly. Rep.
, vol.64
, pp. 1378-1382
-
-
Rudd, R.1
Aleshire, N.2
Zibbell, J.3
Gladden, R.4
-
26
-
-
84955313404
-
Increases in drug and opioid overdose deaths—United States, 2000–2014
-
Rudd, R.A., Aleshire, N., Zibbell, J.E., Gladden, R.M., Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR Morb. Mortal. Wkly. Rep. 64 (2016), 1378–1382.
-
(2016)
MMWR Morb. Mortal. Wkly. Rep.
, vol.64
, pp. 1378-1382
-
-
Rudd, R.A.1
Aleshire, N.2
Zibbell, J.E.3
Gladden, R.M.4
-
27
-
-
85008235154
-
Increases in drug and opioid-Involved overdose Deaths—United States, 2010–2015
-
Rudd, R.A., Seth, P., David, F., Scholl, L., Increases in drug and opioid-Involved overdose Deaths—United States, 2010–2015. MMWR Morb. Mortal. Wkly. Rep. 65 (2016), 1445–1452.
-
(2016)
MMWR Morb. Mortal. Wkly. Rep.
, vol.65
, pp. 1445-1452
-
-
Rudd, R.A.1
Seth, P.2
David, F.3
Scholl, L.4
-
28
-
-
85030311490
-
Epidemic of deaths from fentanyl overdose
-
Socias, M.E., Wood, E., Epidemic of deaths from fentanyl overdose. BMJ, 358, 2017, j4355.
-
(2017)
BMJ
, vol.358
, pp. j4355
-
-
Socias, M.E.1
Wood, E.2
-
29
-
-
85018587344
-
Characteristics of fentanyl overdose—Massachusetts, 2014–2016
-
Somerville, N.J., O'Donnell, J., Gladden, R.M., Zibbell, J.E., Green, T.C., Younkin, M., Ruiz, S., Babakhanlou-Chase, H., Chan, M., Callis, B.P., Kuramoto-Crawford, J., Nields, H.M., Walley, A.Y., Characteristics of fentanyl overdose—Massachusetts, 2014–2016. MMWR Morb. Mortal. Wkly. Rep. 66 (2017), 382–386.
-
(2017)
MMWR Morb. Mortal. Wkly. Rep.
, vol.66
, pp. 382-386
-
-
Somerville, N.J.1
O'Donnell, J.2
Gladden, R.M.3
Zibbell, J.E.4
Green, T.C.5
Younkin, M.6
Ruiz, S.7
Babakhanlou-Chase, H.8
Chan, M.9
Callis, B.P.10
Kuramoto-Crawford, J.11
Nields, H.M.12
Walley, A.Y.13
-
30
-
-
85048200270
-
-
Current Population Survey. Available at: (Accessed 23 January 2018).
-
United States Census Bureau, 2017. Current Population Survey. Available at: https://www.census.gov/programs-surveys/cps.html. (Accessed 23 January 2018).
-
(2017)
-
-
-
31
-
-
84945546387
-
Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health
-
United States Department of Health and Human Services, Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health. 2015.
-
(2015)
-
-
United States Department of Health and Human Services1
-
32
-
-
84884227801
-
Public Health Law Research: Theory and Methods
-
1st edition Jossey-Bass San Francisco, CA
-
Wagenaar, A.C., Burris, S., Public Health Law Research: Theory and Methods. 1st edition, 2013, Jossey-Bass, San Francisco, CA.
-
(2013)
-
-
Wagenaar, A.C.1
Burris, S.2
-
33
-
-
84873671059
-
Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis
-
Walley, A.Y., Xuan, Z., Hackman, H.H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., Ozonoff, A., Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ, 346, 2013, f174.
-
(2013)
BMJ
, vol.346
, pp. f174
-
-
Walley, A.Y.1
Xuan, Z.2
Hackman, H.H.3
Quinn, E.4
Doe-Simkins, M.5
Sorensen-Alawad, A.6
Ruiz, S.7
Ozonoff, A.8
-
34
-
-
84857382804
-
Community-based opioid overdose prevention programs providing naloxone—United States, 2010
-
Wheeler, E., Davidson, P.J., Jones, T.S., Irwin, K.S., Community-based opioid overdose prevention programs providing naloxone—United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 61 (2012), 101–115.
-
(2012)
MMWR Morb. Mortal. Wkly. Rep.
, vol.61
, pp. 101-115
-
-
Wheeler, E.1
Davidson, P.J.2
Jones, T.S.3
Irwin, K.S.4
-
35
-
-
84931827775
-
Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014
-
Wheeler, E., Jones, T.S., Gilbert, M.K., Davidson, P.J., Centers for Disease Control and Prevention, Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR Morb. Mortal. Wkly. Rep. 64 (2015), 631–635.
-
(2015)
MMWR Morb. Mortal. Wkly. Rep.
, vol.64
, pp. 631-635
-
-
Wheeler, E.1
Jones, T.S.2
Gilbert, M.K.3
Davidson, P.J.4
Centers for Disease Control and Prevention5
-
36
-
-
84961618714
-
Barriers to implementation of opioid overdose prevention programs in Ohio
-
Winstanley, E.L., Clark, A., Feinberg, J., Wilder, C.M., Barriers to implementation of opioid overdose prevention programs in Ohio. Subst. Abuse 37 (2016), 42–46.
-
(2016)
Subst. Abuse
, vol.37
, pp. 42-46
-
-
Winstanley, E.L.1
Clark, A.2
Feinberg, J.3
Wilder, C.M.4
|